Condition: Psoriasis · Psoriatic Arthritis · Sponsor: South Valley University
Psoriasis is an immune-mediated inflammatory disease that is highly prevalent worldwide, affecting approximately 2-3% of the world population. It is characterized by red, scaly plaques that can appear on various parts of the body, causing significant physical and psychological burden to affected individuals. The Pathogenesis of PsA involves a complex interplay of genetic, immunological, and environmental factors.Genetic studies have identified several susceptibility loci, including HLA-Cw6 and IL23R, which are shared with psoriasis. Additionally, the presence of certain alleles, such as HLA-B27, is associated with a more severe disease course and a higher likelihood of axial involvement.
This description comes directly from the study's public registry record.
Fawzia Mohamed Abd Elzaher, MSC · +201001238064 · drfawzia11111995@gmail.com
Soheir Abdel-Hamid Ali, Lecturer · +201066877343 · Soher.abdel-hamed@med.svu.edu.eg
Always discuss trial participation with your own doctor first.
| Qena Hospital | Qina, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07086924